Citius Pharma

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a range of anti-infective drugs and unique prescription products in cancer supportive care, oncology, and stem cell therapy. The extensive experience of Citius Pharma's team in the pharmaceutical industry enables us to identify highly attractive opportunities and develop assets with unique commercial advantages and differentiated upside potential.